有効性試験の世界市場予測(〜2025):サービスタイプ別(抗菌/防腐効果試験、消毒効果試験(表面、懸濁液))、用途別(医薬品製造、化粧品・パーソナルケア製品、消費者)

◆英語タイトル:Efficacy Testing Market by Service Type (Antimicrobial/Preservative Efficacy Testing, Disinfectant Efficacy Testing (Surface, Suspension)), Application (Pharmaceutical Manufacturing, Cosmetic & Personal Care Products, Consumer) - Global Forecast to 2025
◆商品コード:BT 5932
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2020年10月20日
◆ページ数:138
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥534,600見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥718,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥880,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
MarketsandMarkets社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

Marketsandmarkets社は有効性試験の世界市場が2020年261百万ドルから2025年333百万ドルまで、年平均5.0%成長すると展望しています。本調査レポートでは、有効性試験の世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、市場動向、サービスタイプ別(消毒効果試験、抗菌/防腐効果試験)分析、用途別(医薬品製造、化粧品・パーソナルケア製品、消費財、医療機器)分析、地域別分析、競争状況、企業情報など、以下の構成でお届けいたします。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・市場動向
・有効性試験の世界市場規模:サービスタイプ別(消毒効果試験、抗菌/防腐効果試験)
・有効性試験の世界市場規模:用途別(医薬品製造、化粧品・パーソナルケア製品、消費財、医療機器)
・有効性試験の世界市場規模:地域別
・競争状況
・企業情報
【レポートの概要】

“The global efficacy testing market is projected to reach USD 333 million by 2025 from USD 261 million in 2020, at a CAGR of 5.0% during the forecast period.” The growth of this market is mainly driven by the increasing use of surface disinfectants and preservatives in pharma, biopharma, and cosmetics industries for contamination control and product stability; growing preference for outsourcing efficacy testing; and the rising adoption of the QbD approach

“By method type, the traditional test method for the largest share of the antimicrobial/preservative testing market”
In the traditional test method, a sample of the pharmaceutical or cosmetic product is inoculated with a microbial suspension of a population of a regulatory recognized key microorganism. This is followed by sampling and the determination of the number of colony-forming units (CFU) and the microbial survival rate with the help of aerobic plate count, surface spread, or membrane filtration techniques after a suitable incubation time. As these test methods are in accordance with the guidelines and standards set by regulatory authorities, they are widely used by service providers

“Asia Pacific: The fastest-growing region in the efficacy testing market.”
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, mainly due to the fast-growing pharmaceutical industry in this region, favorable government policies, and the increasing number of pharmaceutical companies establishing manufacturing facilities in APAC countries.

“North America: the largest share of the efficacy testing market”
North America accounted for the largest share of the efficacy testing market. Factors such as the presence of a wellestablished pharmaceutical industry in the region, the high R&D expenditure, a strong presence of major service providers, and rising outsourcing of analytical testing (including efficacy testing) by pharmaceutical and cosmetic companies in the region are the major factors driving the market growth.

Breakdown of primaries
The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:

• By Respondent– Supply Side- 80%, Demand Side-20%
• By Designation— Executives- 25%, CXOs- 20%, Managers – 55%
• By Region— North America – 50%, Europe – 20%, APAC – 20%, RoW- 10%

The efficacy testing market is dominated by a few globally established players such as Charles River Laboratories (US), WuXi AppTec (China), Eurofins Scientific (Luxembourg), SGS (Switzerland), Intertek Group (UK), Nelson Laboratories, LLC (a Sotera Health company, US), Microbac Laboratories, Inc. (US), Almac Group (UK), North American Science Associates, Inc. (US), Toxikon (US), Pacific Biolabs (US), MSL Solution Providers (UK), Intertek Group PLC (UK), Accugen Laboratories, Inc. (US), Consumer Product Testing Company (US), Lucideon (UK), BioScience Laboratories, Inc. (US), ALS Limited (Australia), Microchem Laboratory (US), Oxford Biosciences Ltd. (UK), Abbott Analytical (Australia), Helvic Laboratories (a Tentamus Company, UK), Honeyman Group Limited (UK), Danish Technological Institute (DTI, Denmark), and BluTest Laboratories Limited (UK).

Research Coverage:
The report segments the efficacy testing market based on region (Asia Pacific, Europe, North America, and RoW), service type (disinfectant efficacy testing and antimicrobial/preservative efficacy testing), application (pharmaceutical manufacturing applications, cosmetics and personal care product applications, consumer product applications, and medical device applications).

The report also provides a comprehensive review of market drivers, challenges, and opportunities in the efficacy testing market
Key Benefits of Buying the Report:
The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the efficacy testing market and provides them information on key market drivers, challenges, and opportunities.

【レポートの目次】

1 INTRODUCTION 21
1.1 OBJECTIVES OF THE STUDY 21
1.2 MARKET DEFINITION 21
1.2.1 INCLUSIONS & EXCLUSIONS 21
1.3 MARKET SCOPE 22
1.3.1 MARKETS COVERED 22
1.3.2 YEARS CONSIDERED FOR THE STUDY 22
1.4 CURRENCY 23
1.5 LIMITATIONS 23
1.6 STAKEHOLDERS 23
1.7 SUMMARY OF CHANGES 23
2 RESEARCH METHODOLOGY 25
2.1 RESEARCH APPROACH 25
2.1.1 SECONDARY DATA 25
2.1.2 PRIMARY DATA 25
2.1.2.1 Breakdown of primary sources 26
FIGURE 1 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 26
2.1.2.2 Key industry insights 27
2.2 MARKET SIZE ESTIMATION 27
FIGURE 2 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS 27
FIGURE 3 EFFICACY TESTING MARKET: FINAL CAGR PROJECTIONS (2020−2025) 28
FIGURE 4 EFFICACY TESTING MARKET: CAGR PROJECTIONS FROM THE ANALYSIS OF DEMAND-SIDE DRIVERS, CHALLENGES, AND OPPORTUNITIES 29
FIGURE 5 EFFICACY TESTING MARKET: SEGMENTAL ASSESSMENT 30
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 31
FIGURE 6 DATA TRIANGULATION METHODOLOGY 31
2.4 MARKET RANKING ANALYSIS 32
2.5 RESEARCH ASSUMPTIONS 32
3 EXECUTIVE SUMMARY 33
FIGURE 7 EFFICACY TESTING MARKET, BY SERVICE TYPE,
2020 VS. 2025 (USD MILLION) 33
FIGURE 8 EFFICACY TESTING MARKET, BY APPLICATION, 2020–2025 34
FIGURE 9 GEOGRAPHICAL SNAPSHOT OF THE EFFICACY TESTING MARKET 35

4 PREMIUM INSIGHTS 36
4.1 EFFICACY TESTING MARKET OVERVIEW 36
FIGURE 10 GROWING PREFERENCE FOR OUTSOURCING EFFICACY TESTING TO DRIVE MARKET GROWTH 36
4.2 ASIA PACIFIC: EFFICACY TESTING MARKET, BY APPLICATION & COUNTRY (2019) 37
FIGURE 11 PHARMACEUTICAL MANUFACTURING APPLICATIONS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2019 37
4.3 DISINFECTANT EFFICACY TESTING MARKET, BY METHOD 37
FIGURE 12 SURFACE TEST METHOD SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 37
5 MARKET OVERVIEW 38
5.1 INTRODUCTION 38
5.2 MARKET DYNAMICS 38
FIGURE 13 EFFICACY TESTING MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES 38
5.2.1 DRIVERS 39
5.2.1.1 Increasing use of surface disinfectants and preservatives in pharma, biopharma, and cosmetics industries for contamination control and product stability 39
5.2.1.1.1 Rising focus on contamination control 39
5.2.1.1.2 Increasing concerns over product stability 39
5.2.1.2 Growing preference for outsourcing efficacy testing 39
5.2.1.3 Rising adoption of the Quality by Design approach 40
5.2.2 OPPORTUNITIES 40
5.2.2.1 Emerging countries in the Asia Pacific region 40
5.2.3 CHALLENGES 41
5.2.3.1 Time-consuming process 41
5.3 REGULATORY ANALYSIS 41
5.3.1 DISINFECTANT EFFICACY TESTING 41
5.3.2 ANTIMICROBIAL EFFICACY TESTING 42
5.4 IMPACT OF COVID-19 ON EFFICACY TESTING SERVICES 42
6 EFFICACY TESTING MARKET, BY SERVICE TYPE 44
6.1 INTRODUCTION 45
TABLE 1 EFFICACY TESTING MARKET, BY SERVICE TYPE, 2018–2025 (USD MILLION) 45
6.2 DISINFECTANT EFFICACY TESTING 45
6.2.1 RISING USE OF SURFACE DISINFECTANTS IN MANUFACTURING FACILITIES FOR CONTAMINATION CONTROL TO BOOST MARKET GROWTH 45
TABLE 2 DISINFECTANT EFFICACY TESTING MARKET, BY REGION,
2018–2025 (USD MILLION) 45
TABLE 3 NORTH AMERICA: DISINFECTANT EFFICACY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 46
TABLE 4 EUROPE: DISINFECTANT EFFICACY TESTING MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 46
TABLE 5 APAC: DISINFECTANT EFFICACY TESTING MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 46
TABLE 6 ROW: DISINFECTANT EFFICACY TESTING MARKET, BY REGION,
2018–2025 (USD MILLION) 47
TABLE 7 DISINFECTANT EFFICACY TESTING MARKET, BY METHOD,
2018–2025 (USD MILLION) 47
6.2.2 SURFACE TEST METHOD 47
TABLE 8 SURFACE TEST METHOD MARKET, BY REGION, 2018–2025 (USD MILLION) 47
TABLE 9 NORTH AMERICA: SURFACE TEST METHOD MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 48
TABLE 10 EUROPE: SURFACE TEST METHOD MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 48
TABLE 11 APAC: SURFACE TEST METHOD MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 48
6.2.3 SUSPENSION TEST METHOD 49
TABLE 12 SUSPENSION TEST METHOD MARKET, BY REGION,
2018–2025 (USD MILLION) 49
TABLE 13 NORTH AMERICA: SUSPENSION TEST METHOD MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 49
TABLE 14 EUROPE: SUSPENSION TEST METHOD MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 49
TABLE 15 APAC: SUSPENSION TEST METHOD MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 50
6.3 ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING 50
6.3.1 AET/PET TESTING ENSURES PRODUCTS HAVE MET THE REQUIRED QUALITY, SAFETY, AND PERFORMANCE STANDARDS 50
TABLE 16 EUROFINS SCIENTIFIC AET TEST PROTOCOL 50
TABLE 17 ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET, BY REGION, 2018–2025 (USD MILLION) 51
TABLE 18 NORTH AMERICA: ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 51
TABLE 19 EUROPE: ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 51
TABLE 20 APAC: ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET,
BY COUNTRY, 2018–2025 (USD MILLION) 52
TABLE 21 ROW: ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET,
BY REGION, 2018–2025 (USD MILLION) 52
TABLE 22 ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET, BY METHOD, 2018–2025 (USD MILLION) 52
6.3.2 TRADITIONAL TEST METHOD 52
TABLE 23 TRADITIONAL TEST METHOD MARKET, BY REGION,
2018–2025 (USD MILLION) 53
6.3.3 RAPID TEST METHOD 53
TABLE 24 RAPID TEST METHOD MARKET, BY REGION, 2018–2025 (USD MILLION) 53

7 EFFICACY TESTING MARKET, BY APPLICATION 54
7.1 INTRODUCTION 55
TABLE 25 EFFICACY TESTING MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 55
7.2 PHARMACEUTICAL MANUFACTURING APPLICATIONS 55
7.2.1 INCREASING FOCUS ON ENSURING THE QUALITY OF DRUGS TO DRIVE MARKET GROWTH 55
TABLE 26 EFFICACY TESTING MARKET FOR PHARMACEUTICAL MANUFACTURING APPLICATIONS, BY REGION, 2018–2025 (USD MILLION) 56
TABLE 27 NORTH AMERICA: EFFICACY TESTING MARKET FOR PHARMACEUTICAL MANUFACTURING APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 56
TABLE 28 EUROPE: EFFICACY TESTING MARKET FOR PHARMACEUTICAL MANUFACTURING APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 56
TABLE 29 APAC: EFFICACY TESTING MARKET FOR PHARMACEUTICAL MANUFACTURING APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 57
7.3 COSMETICS AND PERSONAL CARE PRODUCT APPLICATIONS 57
7.3.1 EFFICACY TESTING IS AN ESSENTIAL PART OF THE STABILITY TESTING REGIMEN OF COSMETICS 57
TABLE 30 EFFICACY TESTING MARKET FOR COSMETICS AND PERSONAL CARE PRODUCT APPLICATIONS, BY REGION, 2018–2025 (USD MILLION) 57
TABLE 31 NORTH AMERICA: EFFICACY TESTING MARKET FOR COSMETICS AND PERSONAL CARE PRODUCT APPLICATIONS, BY COUNTRY,
2018–2025 (USD MILLION) 58
TABLE 32 EUROPE: EFFICACY TESTING MARKET FOR COSMETICS AND PERSONAL CARE PRODUCT APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 58
TABLE 33 APAC: EFFICACY TESTING MARKET FOR COSMETICS AND PERSONAL CARE PRODUCT APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 58
7.4 CONSUMER PRODUCT APPLICATIONS 59
7.4.1 GROWING FOCUS ON A HEALTHY ENVIRONMENT IN HOMES AND INDUSTRIAL FACILITIES TO DRIVE MARKET GROWTH 59
TABLE 34 EFFICACY TESTING MARKET FOR CONSUMER PRODUCT APPLICATIONS,
BY REGION, 2018–2025 (USD MILLION) 59
TABLE 35 NORTH AMERICA: EFFICACY TESTING MARKET FOR CONSUMER PRODUCT APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 59
TABLE 36 EUROPE: EFFICACY TESTING MARKET FOR CONSUMER PRODUCT APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 60
TABLE 37 APAC: EFFICACY TESTING MARKET FOR CONSUMER PRODUCT APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 60
7.5 MEDICAL DEVICE APPLICATIONS 60
7.5.1 IMPOSITION OF RIGOROUS GOVERNMENT REGULATIONS IS A MAJOR FACTOR DRIVING MARKET GROWTH 60
TABLE 38 EFFICACY TESTING MARKET FOR MEDICAL DEVICE APPLICATIONS,
BY REGION, 2018–2025 (USD MILLION) 61
TABLE 39 NORTH AMERICA: EFFICACY TESTING MARKET FOR MEDICAL DEVICE APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 61
TABLE 40 EUROPE: EFFICACY TESTING MARKET FOR MEDICAL DEVICE APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 61
TABLE 41 APAC: EFFICACY TESTING MARKET FOR MEDICAL DEVICE APPLICATIONS,
BY COUNTRY, 2018–2025 (USD MILLION) 62
8 EFFICACY TESTING MARKET, BY REGION 63
8.1 INTRODUCTION 64
TABLE 42 EFFICACY TESTING MARKET, BY REGION, 2018–2025 (USD MILLION) 64
8.2 NORTH AMERICA 64
FIGURE 14 NORTH AMERICA: EFFICACY TESTING MARKET SNAPSHOT 65
TABLE 43 NORTH AMERICA: EFFICACY TESTING MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 65
TABLE 44 NORTH AMERICA: EFFICACY TESTING MARKET, BY SERVICE TYPE,
2018–2025 (USD MILLION) 66
TABLE 45 NORTH AMERICA: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD, 2018–2025 (USD MILLION) 66
TABLE 46 NORTH AMERICA: ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET, BY METHOD, 2018–2025 (USD MILLION) 66
TABLE 47 NORTH AMERICA: EFFICACY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 67
8.2.1 US 67
8.2.1.1 The US dominated the North American efficacy testing market in 2019 67
TABLE 48 US: EFFICACY TESTING MARKET, BY SERVICE TYPE,
2018–2025 (USD MILLION) 67
TABLE 49 US: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD,
2018–2025 (USD MILLION) 68
TABLE 50 US: EFFICACY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 68
8.2.2 CANADA 68
8.2.2.1 Government initiatives to drive market growth in Canada 68
TABLE 51 CANADA: EFFICACY TESTING MARKET, BY SERVICE TYPE,
2018–2025 (USD MILLION) 69
TABLE 52 CANADA: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD,
2018–2025 (USD MILLION) 69
TABLE 53 CANADA: EFFICACY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 69
8.3 EUROPE 69
TABLE 54 EUROPE: EFFICACY TESTING MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 70
TABLE 55 EUROPE: EFFICACY TESTING MARKET, BY SERVICE TYPE,
2018–2025 (USD MILLION) 70
TABLE 56 EUROPE: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD,
2018–2025 (USD MILLION) 70
TABLE 57 EUROPE: ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET,
BY METHOD, 2018–2025 (USD MILLION) 71
TABLE 58 EUROPE: EFFICACY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 71
8.3.1 GERMANY 71
8.3.1.1 Germany is the largest market for efficacy testing services in Europe 71
TABLE 59 GERMANY: EFFICACY TESTING MARKET, BY SERVICE TYPE,
2018–2025 (USD MILLION) 72
TABLE 60 GERMANY: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD,
2018–2025 (USD MILLION) 72
TABLE 61 GERMANY: EFFICACY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 72
8.3.2 FRANCE 72
8.3.2.1 High demand for cosmetic products in France will drive growth in the efficacy testing market for cosmetic product applications 72
TABLE 62 FRANCE: EFFICACY TESTING MARKET, BY SERVICE TYPE,
2018–2025 (USD MILLION) 73
TABLE 63 FRANCE: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD,
2018–2025 (USD MILLION) 73
TABLE 64 FRANCE: EFFICACY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 73
8.3.3 UK 74
8.3.3.1 Efficacy testing market in the UK is primarily driven by the enforcement of regulatory and industry standards 74
TABLE 65 UK: EFFICACY TESTING MARKET, BY SERVICE TYPE,
2018–2025 (USD MILLION) 74
TABLE 66 UK: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD,
2018–2025 (USD MILLION) 74
TABLE 67 UK: EFFICACY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 75
8.3.4 ITALY 75
8.3.4.1 Increasing pharmaceutical production in Italy will drive the demand for efficacy testing for pharmaceutical applications 75
TABLE 68 ITALY: EFFICACY TESTING MARKET, BY SERVICE TYPE,
2018–2025 (USD MILLION) 75
TABLE 69 ITALY: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD,
2018–2025 (USD MILLION) 76
TABLE 70 ITALY: EFFICACY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 76
8.3.5 SPAIN 76
8.3.5.1 Rising R&D expenditure to boost the growth of the Spanish market 76
TABLE 71 SPAIN: EFFICACY TESTING MARKET, BY SERVICE TYPE,
2018–2025 (USD MILLION) 77
TABLE 72 SPAIN: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD,
2018–2025 (USD MILLION) 77
TABLE 73 SPAIN: EFFICACY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 77
8.3.6 REST OF EUROPE 77
TABLE 74 ROE: EFFICACY TESTING MARKET, BY SERVICE TYPE,
2018–2025 (USD MILLION) 78
TABLE 75 ROE: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD,
2018–2025 (USD MILLION) 78
TABLE 76 ROE: EFFICACY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 78

8.4 APAC 79
FIGURE 15 APAC: EFFICACY TESTING MARKET SNAPSHOT 79
TABLE 77 APAC: EFFICACY TESTING MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 80
TABLE 78 APAC: EFFICACY TESTING MARKET, BY SERVICE TYPE,
2018–2025 (USD MILLION) 80
TABLE 79 APAC: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD,
2018–2025 (USD MILLION) 80
TABLE 80 APAC: ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET,
BY METHOD, 2018–2025 (USD MILLION) 80
TABLE 81 APAC: EFFICACY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 81
8.4.1 CHINA 81
8.4.1.1 China is the largest market for efficacy testing services in the Asia Pacific 81
TABLE 82 CHINA: EFFICACY TESTING MARKET, BY SERVICE TYPE,
2018–2025 (USD MILLION) 81
TABLE 83 CHINA: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD,
2018–2025 (USD MILLION) 82
TABLE 84 CHINA: EFFICACY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 82
8.4.2 JAPAN 82
8.4.2.1 Rising R&D investments to drive market growth in Japan 82
TABLE 85 JAPAN: EFFICACY TESTING MARKET, BY SERVICE TYPE,
2018–2025 (USD MILLION) 82
TABLE 86 JAPAN: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD,
2018–2025 (USD MILLION) 83
TABLE 87 JAPAN: EFFICACY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 83
8.4.3 INDIA 83
8.4.3.1 Growing pharmaceutical industry in India to drive market growth 83
TABLE 88 INDIA: EFFICACY TESTING MARKET, BY SERVICE TYPE,
2018–2025 (USD MILLION) 84
TABLE 89 INDIA: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD,
2018–2025 (USD MILLION) 84
TABLE 90 INDIA: EFFICACY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 84
8.4.4 REST OF APAC 84
TABLE 91 ROAPAC: EFFICACY TESTING MARKET, BY SERVICE TYPE,
2018–2025 (USD MILLION) 85
TABLE 92 ROAPAC: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD,
2018–2025 (USD MILLION) 85
TABLE 93 ROAPAC: EFFICACY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 85
8.5 REST OF THE WORLD 86
TABLE 94 ROW: EFFICACY TESTING MARKET, BY SERVICE TYPE,
2018–2025 (USD MILLION) 86
TABLE 95 ROW: DISINFECTANT EFFICACY TESTING MARKET, BY METHOD,
2018–2025 (USD MILLION) 86
TABLE 96 ROW: ANTIMICROBIAL/PRESERVATIVE EFFICACY TESTING MARKET,
BY METHOD, 2018–2025 (USD MILLION) 86
TABLE 97 ROW: EFFICACY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 87
TABLE 98 ROW: EFFICACY TESTING MARKET, BY REGION,
2018–2025 (USD MILLION) 87
8.5.1 LATIN AMERICA 87
TABLE 99 LATAM: EFFICACY TESTING MARKET, BY SERVICE TYPE,
2018–2025 (USD MILLION) 87
TABLE 100 LATAM: EFFICACY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 88
8.5.2 MIDDLE EAST AND AFRICA 88
TABLE 101 MEA: EFFICACY TESTING MARKET, BY SERVICE TYPE,
2018–2025 (USD MILLION) 88
TABLE 102 MEA: EFFICACY TESTING MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 88
9 COMPETITIVE LANDSCAPE 89
9.1 COMPANY EVALUATION MATRIX 89
9.1.1 STARS 89
9.1.2 EMERGING LEADERS 89
9.1.3 PERVASIVE 89
9.1.4 EMERGING COMPANIES 89
FIGURE 16 EFFICACY TESTING MARKET: COMPANY EVALUATION MATRIX (2019) 90
9.2 MARKET RANKING ANALYSIS 91
FIGURE 17 MARKET RANKING IN THE EFFICACY TESTING MARKET (2019) 91
9.3 EFFICACY TESTING MARKET: GEOGRAPHIC ASSESSMENT 91
FIGURE 18 GEOGRAPHIC ASSESSMENT OF KEY PLAYERS IN THE EFFICACY TESTING MARKET (2019) 91
10 COMPANY PROFILES 92
(Business Overview, Products Offered, Recent Developments, MnM View)*
10.1 EFFICACY TESTING SERVICE PROVIDERS 92
10.1.1 EUROFINS SCIENTIFIC 92
FIGURE 19 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019) 93
10.1.2 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 95
FIGURE 20 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.:
COMPANY SNAPSHOT (2019) 95
10.1.3 WUXI APPTEC 97
FIGURE 21 WUXI APPTEC: COMPANY SNAPSHOT (2019) 97
10.1.4 SGS SA 99
FIGURE 22 SGS SA: COMPANY SNAPSHOT (2019) 99
10.1.5 INTERTEK GROUP PLC 101
FIGURE 23 INTERTEK GROUP: COMPANY SNAPSHOT (2019) 101
10.1.6 MICROCHEM LABORATORY 103
10.1.7 ACCUGEN LABORATORIES, INC. 104
10.1.8 PACIFIC BIOLABS 105
10.1.9 NORTH AMERICAN SCIENCE ASSOCIATES 106
10.1.10 TOXIKON 107
10.1.11 BIOSCIENCE LABORATORIES, INC. 108
10.1.12 CONSUMER PRODUCT TESTING COMPANY (CPTC) 109
10.1.13 ALMAC GROUP 110
10.1.14 MSL SOLUTION PROVIDERS 111
10.1.15 NELSON LABORATORIES, LLC (A SOTERA HEALTH COMPANY) 112
10.1.16 ALS LIMITED 113
10.1.17 ABBOTT ANALYTICAL 114
10.1.18 BLUTEST LABORATORIES LIMITED 115
10.1.19 LUCIDEON 116
10.1.20 HELVIC LABORATORIES (A TENTAMUS COMPANY) 117
10.2 MANUFACTURERS OF DISINFECTANTS 118
10.2.1 PROCTER & GAMBLE 118
FIGURE 24 PROCTER & GAMBLE: COMPANY SNAPSHOT (2019) 118
10.2.2 THE CLOROX COMPANY 120
FIGURE 25 THE CLOROX COMPANY: COMPANY SNAPSHOT (2019) 120
10.2.3 3M GROUP 122
FIGURE 26 3M GROUP: COMPANY SNAPSHOT (2019) 122
10.2.4 RECKITT BENCKISER GROUP PLC 124
FIGURE 27 RECKITT BENCKISER GROUP PLC: COMPANY SNAPSHOT (2019) 124
10.2.5 STERIS PLC 126
FIGURE 28 STERIS PLC: COMPANY SNAPSHOT (2019) 126
10.2.6 ECOLAB INC. 128
FIGURE 29 ECOLAB INC.: COMPANY SNAPSHOT (2019) 128
10.2.7 CANTEL MEDICAL CORPORATION 130
FIGURE 30 CANTEL MEDICAL CORPORATION: COMPANY SNAPSHOT (2019) 130
10.2.8 DIVERSEY, INC. 132
10.2.9 MEDLINE INDUSTRIES, INC. 134
10.2.10 BETCO 135
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
11 APPENDIX 136
11.1 DISCUSSION GUIDE 136
11.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 138
11.3 AVAILABLE CUSTOMIZATIONS 140
11.4 RELATED REPORTS 141
11.5 AUTHOR DETAILS 142



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[有効性試験の世界市場予測(〜2025):サービスタイプ別(抗菌/防腐効果試験、消毒効果試験(表面、懸濁液))、用途別(医薬品製造、化粧品・パーソナルケア製品、消費者)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆